Checkpoint immune drugs like pembrolizumab (Keytruda) and nivolumab (Opdivo) are offering hope to people with cancers that were once thought untreatable
A study led by the University of Newcastle (UON) received $544,096 in funding to improve the safety and outcomes of people with dementia after they are discharged from hospital
Revised clinical practice recommending a reduced antivenom dose for snakebite victims has been shown to be successful, signifying huge financial and waste savings for Australian hospitals.
